Cargando…

Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation

Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabo, Roman, Uzzun Sales, Katiuchia, Kosa, Peter, Shylo, Natalia A., Godiksen, Sine, Hansen, Karina K., Friis, Stine, Gutkind, J. Silvio, Vogel, Lotte K., Hummler, Edith, Camerer, Eric, Bugge, Thomas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431340/
https://www.ncbi.nlm.nih.gov/pubmed/22952456
http://dx.doi.org/10.1371/journal.pgen.1002937
_version_ 1782242067738525696
author Szabo, Roman
Uzzun Sales, Katiuchia
Kosa, Peter
Shylo, Natalia A.
Godiksen, Sine
Hansen, Karina K.
Friis, Stine
Gutkind, J. Silvio
Vogel, Lotte K.
Hummler, Edith
Camerer, Eric
Bugge, Thomas H.
author_facet Szabo, Roman
Uzzun Sales, Katiuchia
Kosa, Peter
Shylo, Natalia A.
Godiksen, Sine
Hansen, Karina K.
Friis, Stine
Gutkind, J. Silvio
Vogel, Lotte K.
Hummler, Edith
Camerer, Eric
Bugge, Thomas H.
author_sort Szabo, Roman
collection PubMed
description Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined deficiency in either HAI-1 or HAI-2, along with genes encoding developmentally co-expressed candidate matriptase targets, and screening for the rescue of embryonic development. Hypomorphic mutations in Prss8, encoding the GPI-anchored serine protease, prostasin (CAP1, PRSS8), restored placentation and normal development of HAI-1–deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2–deficient embryos. Inactivation of genes encoding c-Met, protease-activated receptor-2 (PAR-2), or the epithelial sodium channel (ENaC) alpha subunit all failed to rescue embryonic lethality, suggesting that deregulated matriptase-prostasin activity causes developmental failure independent of aberrant c-Met and PAR-2 signaling or impaired epithelial sodium transport. Furthermore, phenotypic analysis of PAR-1 and matriptase double-deficient embryos suggests that the protease may not be critical for focal proteolytic activation of PAR-2 during neural tube closure. Paradoxically, although matriptase auto-activates and is a well-established upstream epidermal activator of prostasin, biochemical analysis of matriptase- and prostasin-deficient placental tissues revealed a requirement of prostasin for conversion of the matriptase zymogen to active matriptase, whereas prostasin zymogen activation was matriptase-independent.
format Online
Article
Text
id pubmed-3431340
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34313402012-09-05 Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation Szabo, Roman Uzzun Sales, Katiuchia Kosa, Peter Shylo, Natalia A. Godiksen, Sine Hansen, Karina K. Friis, Stine Gutkind, J. Silvio Vogel, Lotte K. Hummler, Edith Camerer, Eric Bugge, Thomas H. PLoS Genet Research Article Loss of either hepatocyte growth factor activator inhibitor (HAI)-1 or -2 is associated with embryonic lethality in mice, which can be rescued by the simultaneous inactivation of the membrane-anchored serine protease, matriptase, thereby demonstrating that a matriptase-dependent proteolytic pathway is a critical developmental target for both protease inhibitors. Here, we performed a genetic epistasis analysis to identify additional components of this pathway by generating mice with combined deficiency in either HAI-1 or HAI-2, along with genes encoding developmentally co-expressed candidate matriptase targets, and screening for the rescue of embryonic development. Hypomorphic mutations in Prss8, encoding the GPI-anchored serine protease, prostasin (CAP1, PRSS8), restored placentation and normal development of HAI-1–deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2–deficient embryos. Inactivation of genes encoding c-Met, protease-activated receptor-2 (PAR-2), or the epithelial sodium channel (ENaC) alpha subunit all failed to rescue embryonic lethality, suggesting that deregulated matriptase-prostasin activity causes developmental failure independent of aberrant c-Met and PAR-2 signaling or impaired epithelial sodium transport. Furthermore, phenotypic analysis of PAR-1 and matriptase double-deficient embryos suggests that the protease may not be critical for focal proteolytic activation of PAR-2 during neural tube closure. Paradoxically, although matriptase auto-activates and is a well-established upstream epidermal activator of prostasin, biochemical analysis of matriptase- and prostasin-deficient placental tissues revealed a requirement of prostasin for conversion of the matriptase zymogen to active matriptase, whereas prostasin zymogen activation was matriptase-independent. Public Library of Science 2012-08-30 /pmc/articles/PMC3431340/ /pubmed/22952456 http://dx.doi.org/10.1371/journal.pgen.1002937 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Szabo, Roman
Uzzun Sales, Katiuchia
Kosa, Peter
Shylo, Natalia A.
Godiksen, Sine
Hansen, Karina K.
Friis, Stine
Gutkind, J. Silvio
Vogel, Lotte K.
Hummler, Edith
Camerer, Eric
Bugge, Thomas H.
Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title_full Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title_fullStr Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title_full_unstemmed Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title_short Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
title_sort reduced prostasin (cap1/prss8) activity eliminates hai-1 and hai-2 deficiency–associated developmental defects by preventing matriptase activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431340/
https://www.ncbi.nlm.nih.gov/pubmed/22952456
http://dx.doi.org/10.1371/journal.pgen.1002937
work_keys_str_mv AT szaboroman reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT uzzunsaleskatiuchia reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT kosapeter reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT shylonataliaa reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT godiksensine reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT hansenkarinak reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT friisstine reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT gutkindjsilvio reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT vogellottek reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT hummleredith reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT camerereric reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation
AT buggethomash reducedprostasincap1prss8activityeliminateshai1andhai2deficiencyassociateddevelopmentaldefectsbypreventingmatriptaseactivation